Reuters logo
BRIEF-EMA adopts positive opinion on paediatric investigation plan for IBT's lead product
September 28, 2017 / 6:35 AM / 21 days ago

BRIEF-EMA adopts positive opinion on paediatric investigation plan for IBT's lead product

Sept 28 (Reuters) - INFANT BACTERIAL THERAPEUTICS AB (IBT)

* REG-EUROPEAN MEDICINES AGENCY (EMA) ADOPTS A POSITIVE OPINION ON THE PAEDIATRIC INVESTIGATION PLAN FOR IBT‘S LEAD PRODUCT

* ‍WE ARE NOW PREPARING FOR PHASE 3 STUDY - CEO​ Source text for Eikon: Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below